Bayer CropScience announced its unaudited financial results for the quarter and half-year ended September 30, 2025. The Board of Directors also declared an interim dividend of ₹90 per equity share. Revenue from operations stood at ₹15,534 million for the quarter. The interim dividend will be paid on December 3, 2025, to shareholders on record as of November 14, 2025.
Q2 2026 Financial Performance
Bayer CropScience reported revenue from operations of ₹15,534 million for the quarter ended September 30, 2025 (Q2 2026), compared to ₹17,382 million in Q2 2025. Total income for Q2 2026 reached ₹15,672 million, while profit for the period was ₹1,527 million.
For the six months ended September 30, 2025, revenue from operations totaled ₹34,680 million, and total comprehensive income for the period was ₹4,304 million.
Interim Dividend Announcement
The Board of Directors has declared an interim dividend of ₹90 per equity share of ₹10 each. This dividend payout, amounting to ₹4,045 million, will be distributed to shareholders whose names appear on the register as of the record date, November 14, 2025. The dividend payment date is set for December 3, 2025.
Key Financial Metrics
Key financial figures (in millions) for the quarter ended September 30, 2025, compared to the previous quarter (June 30, 2025) and the corresponding quarter of the previous year (September 30, 2024) are as follows:
- Revenue from Operations: ₹15,534 (vs. ₹19,146 and ₹17,382)
- Profit Before Tax: ₹2,003 (vs. ₹3,352 and ₹1,901)
- Profit for the period: ₹1,527 (vs. ₹2,787 and ₹1,363)
For the six months ended September 30, 2025, the figures are:
- Revenue from Operations: ₹34,680 million
- Profit Before Tax: ₹5,355 million
- Profit for the period: ₹4,314 million
Source: BSE
